- Country: USA
- Summary: Laboratory Services - Membrane Proteome Array Screening for Novel Monoclonal Antibody target identification.
- UST Ref No: 124461817
- Deadline: 21 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N94025Q00186
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00186 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-05. The North American Industry Classification (NAICS) Code is 514380 and the business size standard is $19m. However, this solicitation is not set aside for small business. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to contract on a sole source basis with Integral Molecular Inc. of Philadelphia, PA Instruments America Inc., laboratory services for Membrane Proteome Array Screening for novel monoclonal antibody target identification.
SCOPE OF WORK/TASKSIntegral Molecular shall perform Membrane Proteome Array (MPA) screening services and a Secreted Proteome Library (SPL) to identify binding targets for monoclonal antibodies provided by the Unit on Skeletal Genomics, Division of Translational Medicine, NICHD. The monoclonal antibodies were already expressed recombinantly, based on sequences obtained from patients over the course of the last several months. The contractor will use its proprietary live-cell, flow cytometry-based platform to screen each antibody against a panel of over 6,000 native human membrane proteins.The following tasks are required:• Receive and qualify monoclonal antibody samples.
• Perform MPA screening against full-length human membrane proteins.
• Analyze binding specificity and identify targets.
• Provide a summary report of results in electronic format... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLaboratory Services - Membrane Proteome Array Screening for Novel Monoclonal Antibody target identification. - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Laboratory Services - Membrane Proteome Array Screening for Novel Monoclonal Antibody target identification.. This tender is published on USARFP under UST Ref No: 124461817 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-21.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
